| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 17.705 | 158.582 | 240.872 | 256.669 | 233.642 | 225.157 | 273.107 | 315.528 | 345.250 | 398.643 |
| Total Income - EUR | 17.710 | 158.625 | 240.968 | 256.669 | 233.661 | 229.429 | 273.107 | 315.781 | 346.578 | 398.653 |
| Total Expenses - EUR | 16.698 | 136.962 | 163.543 | 217.845 | 208.540 | 205.141 | 224.709 | 269.351 | 310.115 | 368.196 |
| Gross Profit/Loss - EUR | 1.013 | 21.664 | 77.425 | 38.824 | 25.121 | 24.289 | 48.398 | 46.430 | 36.463 | 30.457 |
| Net Profit/Loss - EUR | 487 | 20.072 | 72.277 | 36.259 | 22.784 | 22.191 | 45.908 | 43.327 | 32.997 | 25.437 |
| Employees | 2 | 0 | 0 | 4 | 3 | 4 | 4 | 4 | 4 | 3 |
Check the financial reports for the company - Neurotim Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 50.135 | 102.683 | 96.245 | 90.454 | 83.412 | 77.508 | 74.887 | 68.802 | 94.563 | 87.507 |
| Current Assets | 17.894 | 28.826 | 80.465 | 71.760 | 19.948 | 36.033 | 41.580 | 114.660 | 44.760 | 90.327 |
| Inventories | 5.937 | 10.858 | 0 | 1.330 | 0 | 0 | 0 | 4.134 | 0 | 0 |
| Receivables | 3.254 | 12.906 | 65.790 | 63.971 | 14.420 | 29.382 | 7.724 | 69.443 | 33.250 | 46.147 |
| Cash | 8.703 | 5.063 | 14.674 | 6.459 | 5.528 | 6.651 | 33.856 | 41.082 | 11.510 | 44.181 |
| Shareholders Funds | 532 | 20.599 | 72.803 | 93.679 | 22.835 | 44.593 | 45.956 | 43.376 | 39.200 | 25.485 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 67.498 | 110.910 | 103.907 | 68.536 | 80.525 | 68.947 | 70.510 | 140.086 | 100.122 | 152.349 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neurotim Med Srl